NEW HAVEN, Conn., Aug. 10, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that Michael Kishbauch, President and Chief Executive Officer of Achillion, will present a corporate overview at the 2012 Wedbush Pacgrow Lifesciences Management Access Conference. The presentation will take place at Le Parker Meridien Hotel in New York, NY on Tuesday, August 14, 2012 at 12:45 p.m. EDT. The live audio broadcasts and the subsequent archived webcasts of the Company's presentation will be available on the Company's website, http://www.achillion.com , under the "News Center" section. The audio recording will be archived for 30 days following the live presentation. Please connect to Achillion's website several minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary. About Achillion Pharmaceuticals Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. Achillion's proven discovery and development teams have advanced multiple product candidates with novel mechanisms of action. Achillion is focused on solutions for the most challenging problems in infectious disease including HCV and resistant bacterial infections. For more information on Achillion Pharmaceuticals, please visit www.achillion.com or call 1-203-624-7000.
CONTACT: Glenn Schulman Achillion Pharmaceuticals, Inc. Tel. (203) 624-7000 firstname.lastname@example.org Investors: Mary Kay Fenton Achillion Pharmaceuticals, Inc. Tel. (203) 624-7000 email@example.com